Featuring insights from Thad Meese, MBA, Director, Innovations Development
Bernardo Perez-Villa, MD, MSc, Senior Engagement Partner for Cleveland Clinic Innovations, Florida Market shares insights on the future of AI integration in oncology alongside leading experts from UVA Health, Baptist Health South Florida, and Tempus AI.
At the forefront of ophthalmic innovation, Justis P. Ehlers, MD, FASRS, and Sunil Srivastava, MD, of Cleveland Clinic's Cole Eye Institute are advancing retinal care through AI-powered imaging technology that provides real-time surgical guidance and personalized treatment plans. Their work integrates artificial intelligence with advanced optical imaging to treat retinal diseases with unprecedented precision, establishing new standards for ophthalmology while accelerating drug development processes.
Cleveland Clinic's Discovery and Innovation Forum brought together distinguished healthcare technology leaders to address the critical challenge of scaling medical innovation from laboratory breakthrough to commercial success. Led by Geoff Vince, PhD, Chief of Cleveland Clinic Innovations and Department Chair of Biomedical Engineering, the panel "From Science to Commercialization: How Do We Scale Healthcare Innovation?" emphasized that successful healthcare commercialization requires a problem-first innovation strategy and seamless integration into clinical workflows.